Ultromics Raises $33M in Series B Funding
- Ultromics, an Oxford, UK-based company focused on advancing AI enabled cardiovascular imaging solutions, raised $33M in series B funding
- The round was led by Blue Venture Fund with participation from Optum Ventures, GV and Oxford Sciences Innovation
- The company intends to use the funds to accelerate the use of AI-enabled echocardiograms to improve patient care
- The company provides automated software powered by AI that allows clinicians to make fast, accurate decisions when using ultrasound images to diagnose cardiovascular disease
- The EchoGo Core and EchoGo Pro platforms deliver accurate assessments of heart function that support the diagnosis of coronary artery disease
